Comparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery

Diana Chabané Schmidt1, Torben Martinussen2, Ameenat Lola Solebo3,4

  • 1Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.

Acta Ophthalmologica
|August 12, 2024
PubMed

Insights

Low-dose glucocorticoid treatment after pediatric cataract surgery reduced glaucoma risk in children with longer eyes. High-dose glucocorticoids should be used sparingly in this population to minimize adverse effects.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Endocrinology

Background:

  • Glucocorticoid treatment is vital post-pediatric cataract surgery to manage inflammation.
  • However, high-dose glucocorticoids may increase risks of secondary glaucoma and hypothalamic-pituitary-adrenal axis suppression.

Purpose of the Study:

  • To compare glaucoma outcomes between high-dose and low-dose postoperative glucocorticoid regimens in children undergoing cataract surgery.

Main Methods:

  • A cohort study of Danish children (under 10 years) who had cataract surgery between 2010-2021.
  • Compared sustained ocular hypertension or glaucoma (>3 months) between low-dose and high-dose glucocorticoid groups.
  • High-dose: subconjunctival depot dexamethasone/methylprednisolone plus topical dexamethasone; Low-dose: topical dexamethasone with a shorter duration and lower frequency.

Main Results:

  • 267 children (388 eyes) were analyzed; 95 received high-dose and 173 received low-dose treatment.
  • Survival analysis indicated a reduced risk of glaucoma in the low-dose group for children with axial lengths ≥18 mm.
  • No significant difference in glaucoma risk was observed for children with shorter eyes.

Conclusions:

  • Low-dose glucocorticoid therapy is associated with a lower risk of glaucoma in pediatric cataract surgery patients with axial lengths ≥18 mm.
  • High-dose glucocorticoid use should be minimized in pediatric cataract surgery.
  • Further research may explore optimal glucocorticoid dosing strategies based on ocular parameters.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
530
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
459